🔗 Permalink

Inventor profile of:

Li Long

City:

Lafayette, California

Country:

United States

Published Applications:

Last publication date:

2021-09-09

Top Assignees for applications by Li Long

The entities that hold a legal rights for patent applications filed by inventor Long Li:

FIVE PRIME THERAPEUTICS, INC. 6 South San Francisco, CA United States
Novartis Vaccines and Diagnostics, Inc. 4 Emeryville, CA United States
XOMA TECHNOLOGY LTD. 3 Berkeley, CA United States
XOMA Technology, Ltd. 1 Emeryville, CA United States
EUREKA THERAPEUTICS, INC. 1 Emeryville, CA United States
XOMA TECHNOLOGY LTD. 1 Hamilton, Bermuda
Chiron Corporation 1 Emeryville, CA United States

Recent patent applications by Long Li

Li Long from Lafayette, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-09

US20210277117A1

Chemistry; metallurgy

CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

#2 | 2019-08-29

US20190263900A1

Chemistry; metallurgy

Humanized M-CSF specific monoclonal antibodies, kits, and uses thereof

#3 | 2019-01-03

US20190000920A1

Human necessities

Methods of treating lung cancer

#4 | 2018-07-26

US20180208658A1

Chemistry; metallurgy

CONSTRUCTS TARGETING AFP PEPTIDE/MHC COMPLEXES AND USES THEREOF

#5 | 2018-06-21

US20180171009A1

Chemistry; metallurgy

M-CSF Specific Monoclonal Antibody and Uses Thereof

#6 | 2018-03-22

US20180079815A1

Chemistry; metallurgy

Constructs targeting AFP peptide/MHC complexes and uses thereof

#7 | 2018-01-04

US20180002399A1

Chemistry; metallurgy

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

#8 | 2017-06-01

US20170152311A1

Chemistry; metallurgy

M-CSF specific monoclonal antibody and uses thereof

#9 | 2016-01-21

US20160015809A1

Human necessities

M-CSF specific monoclonal antibody and uses therof

#10 | 2015-07-23

US20150203566A1

Chemistry; metallurgy

FGFR1 EXTRACELLULAR DOMAIN COMBINATION THERAPIES

#11 | 2014-11-20

US20140341900A1

Human necessities

Methods of treating lung cancer

#12 | 2014-08-28

US20140242071A1

Chemistry; metallurgy

M-CSF specific monoclonal antibody and uses thereof

#13 | 2013-05-30

US20130136740A1

Human necessities

METHODS OF TREATING CANCER

#14 | 2012-09-20

US20120237511A1

Chemistry; metallurgy

FGFR1 extracellular domain combination therapies for lung cancer

#15 | 2010-06-03

US20100136007A1

Chemistry; metallurgy

Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

#16 | 2010-06-03

US20100136006A1

Chemistry; metallurgy

Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

#17 | 2009-12-31

US20090324604A1

Chemistry; metallurgy

M-csf specific monoclonal antibody and uses thereof

InventorID:

888119 ⎘